Healthcare -
Biotechnology - NASDAQ - US
$ 0.8783
2.56 %
$ 150 M
Market Cap
-2.2
P/E
Price Target
Average
42.32%
Revenue Forecast
Estimate
32.85%
EBIT
Estimate
--32.61%
Net Income
Estimate
7.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Seres Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MCRB of $1.25 , with forecasts ranging from
a
low of
$1.25 to a high of $1.25 .
MCRB Lowest Price Target
Wall Street Target
1.25 USD
42.32%
MCRB Average Price Target
Wall Street Target
1.25 USD
42.32%
MCRB Highest Price Target
Wall Street Target
1.25 USD
42.32%
REVENUE FORECAST
Revenue Forecast Chart MCRB
EBIT FORECAST
EBIT Forecast Chart MCRB
NET INCOME FORECAST
Net Income Chart MCRB